<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60331">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01818635</url>
  </required_header>
  <id_info>
    <org_study_id>FK-0663</org_study_id>
    <nct_id>NCT01818635</nct_id>
  </id_info>
  <brief_title>To Investigate the Effect of Montelukast on Behavior Problems in Children With Asthma</brief_title>
  <official_title>Phase 4 Study of to Investigation the Effect of Montelukast on Behavior Problems in Children With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fatih University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kecioren Education and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turgut Ozal Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fatih University</source>
  <oversight_info>
    <authority>Turkey: General Directorate of Pharmaceutical and Pharmacy</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study to investigate whether montelukast lead to behavior problems in
      children with asthma.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>To investigate the effect of montelukast on behavior problems in children with asthma</measure>
    <time_frame>8 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Montelukast frequently used in the treatment of asthmatic children. However, we believe that montelukast lead to behavior problems. In this study, we aimed to investigate that intake of montelukast whether lead to behavior problems.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the effects of inhaled corticosteroids and montelukast on the behavior problems.</measure>
    <time_frame>8 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>In this study, it will be compared the effect on behavior changes between intake of inhaled steroid and montelukast.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Asthma, Behavior Problem, Montelukast</condition>
  <eligibility>
    <study_pop>
      <textblock>
        We planned to include who who treated for asthmatic children and healthy controls in the
        study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To have asthmatic children aged 18-60 months

          -  To have that receive prophylactic treatment for asthma

          -  Healthy children will be enrolled among those being brought for routine controls

        Exclusion Criteria:

          -  Children with other chronic disease

          -  Children with chronic drug use (except for the treatment of asthma)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>60 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fatih University Medical School, Ankara, Turkey</last_name>
  </overall_contact>
  <location>
    <facility>
      <name>Fatih University Medical School</name>
      <address>
        <city>Ankara</city>
        <zip>06510</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fatih University Medical School</last_name>
      <email>akelma@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fatih University</name>
      <address>
        <city>Ankara</city>
        <zip>06510</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmet Z Akelma, M.D.</last_name>
      <email>akelma@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 29, 2013</lastchanged_date>
  <firstreceived_date>March 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fatih University</investigator_affiliation>
    <investigator_full_name>Ahmet Z. Akelma</investigator_full_name>
    <investigator_title>Fatih University Medical School</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
